The University of Chicago Header Logo

Connection

Takemasa Tsuji to Interferon-gamma

This is a "connection" page, showing publications Takemasa Tsuji has written about Interferon-gamma.
Connection Strength

0.447
  1. Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors. PLoS One. 2011; 6(8):e23651.
    View in: PubMed
    Score: 0.087
  2. Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes. Blood. 2005 Jul 15; 106(2):470-6.
    View in: PubMed
    Score: 0.056
  3. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity. Int Immunol. 2004 Jun; 16(6):811-7.
    View in: PubMed
    Score: 0.053
  4. IFN-gamma-induced SOCS-1 regulates STAT6-dependent eotaxin production triggered by IL-4 and TNF-alpha. Biochem Biophys Res Commun. 2004 Feb 06; 314(2):468-75.
    View in: PubMed
    Score: 0.052
  5. Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses. Sci Rep. 2015 Oct 08; 5:14896.
    View in: PubMed
    Score: 0.029
  6. Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity. Clin Cancer Res. 2012 Oct 01; 18(19):5449-59.
    View in: PubMed
    Score: 0.023
  7. Inducing efficient cross-priming using antigen-coated yeast particles. J Immunother. 2008 Sep; 31(7):607-19.
    View in: PubMed
    Score: 0.018
  8. 1alpha,25-Dihydroxyvitamin D3 downmodulates the functional differentiation of Th1 cytokine-conditioned bone marrow-derived dendritic cells beneficial for cytotoxic T lymphocyte generation. Cancer Sci. 2006 Feb; 97(2):139-47.
    View in: PubMed
    Score: 0.015
  9. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity. Cancer Res. 2004 Dec 01; 64(23):8754-60.
    View in: PubMed
    Score: 0.014
  10. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo. Immunol Lett. 2004 Aug 15; 95(1):5-11.
    View in: PubMed
    Score: 0.013
  11. Generation of leukemia-specific T-helper type 1 cells applicable to human leukemia cell-therapy. Immunol Lett. 2004 Apr 30; 93(1):17-25.
    View in: PubMed
    Score: 0.013
  12. Generation and targeting of human tumor-specific Tc1 and Th1 cells transduced with a lentivirus containing a chimeric immunoglobulin T-cell receptor. Cancer Res. 2004 Feb 15; 64(4):1490-5.
    View in: PubMed
    Score: 0.013
  13. Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy. Cancer Sci. 2003 Oct; 94(10):924-8.
    View in: PubMed
    Score: 0.013
  14. Functional expression of the TrkC gene, encoding a high affinity receptor for NT-3, in antigen-specific T helper type 2 (Th2) cells. Immunol Lett. 2003 Sep 08; 88(3):221-6.
    View in: PubMed
    Score: 0.013
  15. Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo. Cell Immunol. 2003 Aug; 224(2):98-105.
    View in: PubMed
    Score: 0.012
  16. Differential regulation of VLA-2 expression on Th1 and Th2 cells: a novel marker for the classification of Th subsets. Int Immunol. 2003 Jun; 15(6):701-10.
    View in: PubMed
    Score: 0.012
  17. Th1 cytokine-conditioned bone marrow-derived dendritic cells can bypass the requirement for Th functions during the generation of CD8+ CTL. J Immunol. 2001 Oct 01; 167(7):3687-91.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.